JMPHF (Leveljump Healthcare) Equity-to-Asset: 0.16 (As of Mar. 2026) — 59% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Leveljump Healthcare Equity-to-Asset?

Leveljump Healthcare JMPHF Equity-to-Asset is 0.16 as of Mar. 2026, which is 59% below its 10-year median of 0.39. The stock has 1 warning sign investors should review.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Leveljump Healthcare's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $2.19 Mil. Leveljump Healthcare's Total Assets for the quarter that ended in Mar. 2026 was $13.68 Mil. Therefore, Leveljump Healthcare's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.16.

The historical rank and industry rank for Leveljump Healthcare's Equity-to-Asset or its related term are showing as below:

JMPHF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.05   Med: 0.39   Max: 0.82
Current: 0.16

During the past 7 years, the highest Equity to Asset Ratio of Leveljump Healthcare was 0.82. The lowest was 0.05. And the median was 0.39.

JMPHF's Equity-to-Asset is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.595 vs JMPHF: 0.16

Leveljump Healthcare  (OTCPK:JMPHF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Leveljump Healthcare Equity-to-Asset Related Terms


Leveljump Healthcare Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Leveljump Healthcare's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leveljump Healthcare Equity-to-Asset Chart

Leveljump Healthcare Annual Data
Trend Aug19 Aug20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial 0.48 0.51 0.25 0.30 0.17

Leveljump Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.29 0.29 0.17 0.16

JMPHF vs TMO, DHR, IDXX: Equity-to-Asset Comparison

For the Diagnostics & Research subindustry, Leveljump Healthcare's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leveljump Healthcare Equity-to-Asset vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Leveljump Healthcare's Equity-to-Asset falls into.



Leveljump Healthcare Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Leveljump Healthcare's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=2.373/13.721
=0.17

Leveljump Healthcare's Equity to Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

Equity to Asset (Q: Mar. 2026 )=Total Stockholders Equity/Total Assets
=2.19/13.681
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.16 mean?
Leveljump Healthcare (JMPHF) has a Equity-to-Asset of 0.16 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Leveljump Healthcare and its competitors. This is 59% below median its historical median of 0.39. Over the past decade, Leveljump Healthcare's Equity-to-Asset has ranged from 0.05 to 0.82.
Is Leveljump Healthcare's Equity-to-Asset too high?
Leveljump Healthcare's current Equity-to-Asset of 0.16 is 59% below median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.82. The Medical Diagnostics & Research industry median Equity-to-Asset is 0.60. Leveljump Healthcare's value of 0.16 is 73.1% below this industry median.
How does Leveljump Healthcare's Equity-to-Asset compare to TMO and DHR?
Leveljump Healthcare's Equity-to-Asset of 0.16 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Equity-to-Asset is 0.60. Leveljump Healthcare's value of 0.16 is 73.1% below this benchmark. Historically, Leveljump Healthcare's own Equity-to-Asset has ranged from 0.05 to 0.82 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.60, Leveljump Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Diagnostics & Research company?
The median Equity-to-Asset among Medical Diagnostics & Research companies is 0.60, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leveljump Healthcare's current Equity-to-Asset of 0.16 is 73.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Leveljump Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leveljump Healthcare's current Equity-to-Asset is 0.16, which is 59% below median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Equity-to-Asset of 0.16. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Equity-to-Asset is 0.16, which is 59% below median its 10-year median of 0.39 and 73.1% below the Medical Diagnostics & Research industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Equity-to-Asset is 0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Leveljump Healthcare Business Description

Other Exchanges JUMP:Canada
Address 52 Scarsdale Road, Suite 207, Toronto, ON, CAN, M3B 2R7
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.